Nitches Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
John Morgan
Chief executive officer
US$320.0k
Total compensation
| CEO salary percentage | 37.5% |
| CEO tenure | 3.3yrs |
| CEO ownership | 2.6% |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Feb 29 2024 | n/a | n/a | -US$2m |
| Nov 30 2023 | n/a | n/a | -US$777k |
| Aug 31 2023 | US$320k | US$120k | -US$827k |
| May 31 2023 | n/a | n/a | -US$669k |
| Feb 28 2023 | n/a | n/a | -US$500k |
| Nov 30 2022 | n/a | n/a | -US$520k |
| Aug 31 2022 | US$102k | US$102k | -US$834k |
| May 31 2022 | n/a | n/a | -US$15m |
| Feb 28 2022 | n/a | n/a | -US$20m |
| Nov 30 2021 | n/a | n/a | -US$20m |
| Aug 31 2021 | US$250k | US$150k | -US$19m |
Compensation vs Market: John's total compensation ($USD320.00K) is below average for companies of similar size in the US market ($USD663.90K).
Compensation vs Earnings: John's compensation has increased whilst the company is unprofitable.
CEO
John Morgan (46 yo)
3.3yrs
Tenure
US$320,000
Compensation
Mr. John B. Morgan serves as the Chief Executive Officer and Director since January 2022 at Lee Pharmaceuticals, Inc. He serves as the Chief Executive Officer of Nitches Inc. since January 2021 and also it...